Literature DB >> 20454975

L-methionine-induced alterations in molecular signatures in MCF-7 and LNCaP cancer cells.

Maximo A Benavides1, Dong Hu, Marie Kristine Baraoidan, Annette Bruno, Pan Du, Simon Lin, Wancai Yang, Kirby I Bland, William E Grizzle, Maarten C Bosland.   

Abstract

BACKGROUND: Methionine inhibits proliferation of breast and prostate cancer cells. Here, we determined the influence of L-methionine on functional molecular signatures in these cell lines.
METHODS: MCF-7 and LNCaP cells were treated with L-methionine (5 mg/ml) for 72 h. Changes in molecular signatures of these cells were examined by microarray analysis of 15,814 probes in triplicate experiments.
RESULTS: In LNCaP cells, 325 genes were up-regulated by methionine, and 517 genes down-regulated. In MCF-7 cells, 86 genes were up-regulated and 135 genes down-regulated. Ninety-eight genes were regulated in the same direction by methionine in both cells lines, and five other genes were changed in expression in opposite directions.
CONCLUSION: Several of the up-regulated genes encode proteins involved in cellular redox regulation, suggesting that methionine may enhance antioxidant mechanisms. Many of the down-regulated genes belong to protein kinase families that may be related to the anti-proliferative effects of methionine on breast and prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20454975      PMCID: PMC2988108          DOI: 10.1007/s00432-010-0897-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

Review 1.  Mechanisms through which sulfur amino acids control protein metabolism and oxidative status.

Authors:  Sonia Métayer; Iban Seiliez; Anne Collin; Sophie Duchêne; Yves Mercier; Pierre-André Geraert; Sophie Tesseraud
Journal:  J Nutr Biochem       Date:  2007-08-17       Impact factor: 6.048

2.  Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells.

Authors:  J G Judde; M Ellis; P Frost
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

3.  Suppression by L-methionine of cell cycle progression in LNCaP and MCF-7 cells but not benign cells.

Authors:  Maximo A Benavides; Karen L Hagen; Wenfeng Fang; Pan Du; Simon Lin; Mary P Moyer; Wancai Yang; Kirby I Bland; William E Grizzle; Maarten C Bosland
Journal:  Anticancer Res       Date:  2010-06       Impact factor: 2.480

4.  Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.

Authors:  Qing Ji; Chisa Aoyama; Yih-Dar Nien; Paul I Liu; Peter K Chen; Lilly Chang; Frank Z Stanczyk; Andrew Stolz
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

5.  Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.

Authors:  Qing Ji; Lilly Chang; David VanDenBerg; Frank Z Stanczyk; Andrew Stolz
Journal:  Prostate       Date:  2003-03-01       Impact factor: 4.104

6.  Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease.

Authors:  Karen S SantaCruz; Eugenia Yazlovitskaya; Julie Collins; Jeff Johnson; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

7.  Gene expression phenotypic models that predict the activity of oncogenic pathways.

Authors:  Erich Huang; Seiichi Ishida; Jennifer Pittman; Holly Dressman; Andrea Bild; Mark Kloos; Mark D'Amico; Richard G Pestell; Mike West; Joseph R Nevins
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

8.  Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily.

Authors:  Stefano Toppo; Stefano Vanin; Valentina Bosello; Silvio C E Tosatto
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

Review 9.  Glutathione: an overview of biosynthesis and modulation.

Authors:  M E Anderson
Journal:  Chem Biol Interact       Date:  1998-04-24       Impact factor: 5.192

10.  nuID: a universal naming scheme of oligonucleotides for illumina, affymetrix, and other microarrays.

Authors:  Pan Du; Warren A Kibbe; Simon M Lin
Journal:  Biol Direct       Date:  2007-05-31       Impact factor: 4.540

View more
  5 in total

1.  L-Methionine inhibits growth of human pancreatic cancer cells.

Authors:  Maximo A Benavides; Maarten C Bosland; Cássio P da Silva; Claudia T Gomes Sares; Alana M Cerqueira de Oliveira; Rafael Kemp; Rodolfo B dos Reis; Vilma R Martins; Suely V Sampaio; Kirby I Bland; William E Grizzle; José S dos Santos
Journal:  Anticancer Drugs       Date:  2014-02       Impact factor: 2.248

Review 2.  One-carbon metabolism and ionizing radiation: a multifaceted interaction.

Authors:  Isabelle R Miousse; Julia Tobacyk; Stepan Melnyk; S Jill James; Amrita K Cheema; Marjan Boerma; Martin Hauer-Jensen; Igor Koturbash
Journal:  Biomol Concepts       Date:  2017-05-24

Review 3.  L-methionase: a therapeutic enzyme to treat malignancies.

Authors:  Bhupender Sharma; Sukhdev Singh; Shamsher S Kanwar
Journal:  Biomed Res Int       Date:  2014-08-31       Impact factor: 3.411

4.  l-Methionine may modulate the assembly of SARS-CoV-2 by interfering with the mechanism of RNA polymerase.

Authors:  Maximo A Benavides
Journal:  Med Hypotheses       Date:  2022-02-14       Impact factor: 1.538

5.  Methionine Supplementation Affects Metabolism and Reduces Tumor Aggressiveness in Liver Cancer Cells.

Authors:  Farida Tripodi; Beatrice Badone; Marta Vescovi; Riccardo Milanesi; Simona Nonnis; Elisa Maffioli; Marcella Bonanomi; Daniela Gaglio; Gabriella Tedeschi; Paola Coccetti
Journal:  Cells       Date:  2020-11-16       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.